Traduction de «fracture risk in elders » (Français → Néerlandais) :

Lévothyroxine and fracture risk in elders.
Levothyroxine and fracture risk in elders.

Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.
Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the of falls in elderly high-risk women.

26. Falsey A, Hennessey P, Formica M et al. Respiratory syncytial virus infection in elderly and high-risk adults.
Falsey A, Hennessey P, Formica M et al. Respiratory syncytial virus infection in elderly and high-risk adults.

Yu EW, Bauer SR, Bain PA et al. Proton pump inibitors and risk of fractures: a meta-analysis of 11 international studies.
Aseeri M, Schroeder T, Kramer J et al. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients.

Predicting risk of osteoporotic and hip fracture in the united Kingdom : prospective independent and external validation of QFractureScores.
Predicting risk of osteoporotic and hip fracture in the United Kingdom : prospective independent and external validation of QFractureScores.

Turner MR, Camacho X, Fischer HD et al. Lévothyroxine dose and risk of fractures in older adults : nested case-control study.
Turner MR, Camacho X, Fischer HD et al. Levothyroxine dose and risk of fractures in older adults : nested case-control study.

Ce serait surtout le cas lors de l’utilisation de doses élevées et de traitement de longue durée. [FDA Drug safety communication: possible increased risk of fractures of the hip, wrist and spine with the use of proton pump inhibitors.
Dit zou vooral het geval zijn bij hogere doses en langere behandelingsduur [FDA Drug safety communication: possible increased risk of fractures of the hip, wrist and spine with the use of proton pump inhibitors.